GR3006081T3 - - Google Patents

Info

Publication number
GR3006081T3
GR3006081T3 GR920402410T GR920402410T GR3006081T3 GR 3006081 T3 GR3006081 T3 GR 3006081T3 GR 920402410 T GR920402410 T GR 920402410T GR 920402410 T GR920402410 T GR 920402410T GR 3006081 T3 GR3006081 T3 GR 3006081T3
Authority
GR
Greece
Prior art keywords
thrombocyto
diacylglycerols
inhibition
preparing
compounds
Prior art date
Application number
GR920402410T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006081T3 publication Critical patent/GR3006081T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
    • C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Monitoring And Testing Of Nuclear Reactors (AREA)
  • Hydrogenated Pyridines (AREA)
  • Breakers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measurement Of Force In General (AREA)
GR920402410T 1986-07-30 1992-10-26 GR3006081T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863625738 DE3625738A1 (de) 1986-07-30 1986-07-30 2-acyloxypropylamin-derivate, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
GR3006081T3 true GR3006081T3 (el) 1993-06-21

Family

ID=6306287

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402410T GR3006081T3 (el) 1986-07-30 1992-10-26

Country Status (17)

Country Link
US (1) US4855489A (el)
EP (1) EP0255126B1 (el)
JP (1) JPS6348250A (el)
KR (1) KR880001577A (el)
AT (1) ATE81499T1 (el)
AU (1) AU597090B2 (el)
CA (1) CA1318670C (el)
DD (1) DD266349A5 (el)
DE (2) DE3625738A1 (el)
DK (1) DK374887A (el)
ES (1) ES2052525T3 (el)
FI (1) FI89042C (el)
GR (1) GR3006081T3 (el)
HU (1) HU197720B (el)
IL (1) IL83368A (el)
SU (1) SU1470177A3 (el)
ZA (1) ZA875640B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705384A1 (de) * 1987-02-20 1988-09-01 Goedecke Ag 2-propylamin-derivate, verfahren zu deren herstellung sowie deren verwendung
EP0296545B1 (de) * 1987-06-25 1992-03-04 Hoechst Aktiengesellschaft Ein neues Antibiotikum, Fumifungin, ein mikrobielles Verfahren zu seiner Herstellung und seine Verwendung als Arzneimittel
DE3836987A1 (de) * 1988-10-31 1990-05-23 Goedecke Ag 2-aminocarbonsaeuren und deren derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
GB2321455A (en) 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
US7476656B2 (en) * 2004-11-09 2009-01-13 University Of Florida Research Foundation, Inc. Fluorescent affinity tag to enhance phosphoprotein detection and characterization
US8930331B2 (en) 2007-02-21 2015-01-06 Palantir Technologies Providing unique views of data based on changes or rules
US9092482B2 (en) 2013-03-14 2015-07-28 Palantir Technologies, Inc. Fair scheduling for mixed-query loads

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU66207A1 (el) * 1972-09-29 1974-04-02
CH618958A5 (en) * 1975-07-01 1980-08-29 Ciba Geigy Ag Process for the preparation of novel secondary acyloxyamines
DE2820892A1 (de) * 1978-05-12 1979-11-22 Nattermann A & Cie Neue strukturanaloga von glyveriden und verfahren zu deren herstellung
GB2172284B (en) * 1985-03-12 1988-07-27 Ciba Geigy Ag Nitrogen-containing additives for non-aqueous functional fluids

Also Published As

Publication number Publication date
DK374887A (da) 1988-01-31
DD266349A5 (de) 1989-03-29
ES2052525T3 (es) 1994-07-16
EP0255126A2 (de) 1988-02-03
SU1470177A3 (ru) 1989-03-30
DE3782207D1 (de) 1992-11-19
HUT44228A (en) 1988-02-29
EP0255126B1 (de) 1992-10-14
FI873313A (fi) 1988-01-31
IL83368A (en) 1991-05-12
JPS6348250A (ja) 1988-02-29
FI89042C (fi) 1993-08-10
CA1318670C (en) 1993-06-01
IL83368A0 (en) 1987-12-31
DK374887D0 (da) 1987-07-17
AU7624887A (en) 1988-02-04
HU197720B (en) 1989-05-29
US4855489A (en) 1989-08-08
DE3625738A1 (de) 1988-02-11
ATE81499T1 (de) 1992-10-15
FI89042B (fi) 1993-04-30
FI873313A0 (fi) 1987-07-29
KR880001577A (ko) 1988-04-25
ZA875640B (en) 1988-11-30
AU597090B2 (en) 1990-05-24
EP0255126A3 (en) 1989-01-11

Similar Documents

Publication Publication Date Title
ES8607732A1 (es) Procedimiento para producir un preparado implantable de un peptido regulador, uno de sus analogos o una de sus sales fisiologicamente compatibles.
DE3166441D1 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
BG45700A3 (en) Method for preparing of alpha- heterocyclic substituted tolunitriles
DE3163867D1 (en) Novel substituted pyrazinyl-1,2,4-oxadiazol-5-ones, a process for preparing same and a pharmaceutical composition containing same
IL67697A (en) 6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them
PH30944A (en) Substituted pyridine-sulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds.
ES8600737A1 (es) Procedimiento de preparar compuestos de sulfonio
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
DE3161059D1 (en) Piperazine derivative, processes for preparing the same and therapeutic compositions containing it
JO1406B1 (en) Chemical compounds
GR3006081T3 (el)
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
GR1000467B (el) Μεθοδος παρασκευης τρικυκλικων παραγωγων 3-οξο-προπανονιτριλιου.
PT84716A (en) Process for the preparation of insecticidal compositions containing six-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines
NO874268D0 (no) Fremgangsmaate for fremstilling av n-substituerte piperazinoner.
PT72362B (en) Process for preparing novel aldehyde 0aducts of triaterene
PH24207A (en) 2-acylamino-6-amino-4,5,6,7-tetrahydrobenzothiazoles
IL77357A (en) N-substituted aziridine-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
IT8321507A0 (it) Procedimento di preparazione fermentativa di l-leucina.
DE3576498D1 (de) 2-sulfamoyl-1h-indole-derivate zur behandlung von hohem intraocularem druck.
GR3033709T3 (en) Process for the preparation of L-tertiairy-leucin by transamination.